SOLV vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both Solventum ( SOLV Quick QuoteSOLV - ) and Medpace ( MEDP Quick QuoteMEDP - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Medpace ( MEDP ) Stock Declines While Market Improves: Some Information for Investors
Medpace (MEDP) closed at $536.17 in the latest trading session, marking a -1.42% move from the prior day.
This RH Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Edison Intl ( NYSE:EIX ) , American Tower ( NYSE:AMT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
Is Janus Henderson Small/Mid Cap Growth Alpha ETF ( JSMD ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Medpace ( MEDP ) Dips More Than Broader Market: What You Should Know
In the most recent trading session, Medpace (MEDP) closed at $487.95, indicating a -1.88% shift from the previous trading day.
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System
Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
Stryker Expands R&D Facility in India to Boost Medtech Innovation
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
COO's premium lens strategy, MiSight myopia leadership, and fertility portfolio fuel long-term growth despite near-term headwinds.
Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus
Zacks highlights winners like LendingTree, AutoZone, and Johnson & Johnson as its proven stock-picking strategies continue to shine.
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
Sight Sciences highlights a new meta-analysis showing OMNI delivers lasting safety, efficacy and economic value in glaucoma treatment.
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
ARAY sees strong order momentum, APAC growth and CyberKnife demand, but soft product sales and regional headwinds cloud near-term gains.
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay shares surge after the FDA cleared its accelerated Deep TMS protocol, offering faster depression treatment with strong clinical results.
CAH Strengthens Distribution With New Consumer Health Logistics Hub
Cardinal Health opens a 350,000-square-foot Consumer Health Logistics Center in Ohio, strengthening its pharmaceutical supply chain and advancing its multiyear infrastructure expansion strategy.
GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
GE HealthCare debuts AI-powered Voluson Performance ultrasound systems, enhancing women's health imaging with faster, smarter diagnostics.
SOLV or MEDP: Which Is the Better Value Stock Right Now?
SOLV vs. MEDP: Which Stock Is the Better Value Option?
ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5
Intuitive Surgical unveils real-time surgical insights on its da Vinci 5, enhancing precision, safety, and efficiency with advanced software features.
GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
GE HealthCare moves to strengthen its neurology portfolio by acquiring icometrix, aiming to integrate AI-driven brain MRI solutions into its imaging platforms.
Why Medpace ( MEDP ) Outpaced the Stock Market Today
Medpace (MEDP) reached $496.41 at the closing of the latest trading day, reflecting a +1.18% change compared to its last close.
MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care
Merit Medical secures CE Mark for Embosphere, expanding its use in knee osteoarthritis treatment with a minimally invasive alternative.
The Zacks Analyst Blog Highlights Hasbro, Robinhood Markets, Interactive Brokers, Celsius and Medpace
Hasbro, Robinhood, Interactive Brokers, Celsius, and Medpace are top non-tech Nasdaq stocks showing strong growth and robust earnings potential in 2025.
Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study
PLSE wins FDA IDE approval for its NANOCLAMP AF study, advancing nsPFA tech as a novel option in atrial fibrillation surgery.
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025
Non-tech Nasdaq standouts like HAS, HOOD, IBKR, CELH and MEDP are fueling 2025's index surge.
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.
Dentsply Sirona Retains Wellspect Following Strategic Review
XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum.
Lifeward Achieves European Approval for Latest ReWalk Exoskeleton
LFWD secures CE mark for its ReWalk 7 Personal Exoskeleton, unlocking new European sales potential with advanced features.
Medpace ( MEDP ) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw Medpace (MEDP) settling at $492.09, representing a +1.05% change from its previous close.
Cardinal Health Expands At-Home Solutions With New Texas Facility
CAH announces the opening of a new distribution center in Texas, which is likely to support its at-Home Solutions business.
MYGN Stock Might Gain on The Lancet Study Backing Precise MRD
Myriad Genetics' Precise MRD study in The Lancet shows ctDNA detection power in oligometastatic ccRCC, supporting oncology growth plans.
GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System
GE HealthCare's FDA-cleared Revolution Vibe CT promises faster, AI-driven cardiac imaging with improved clarity, boosting efficiency and patient comfort.
PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq
PacBio collaborates with EpiCypher to integrate Fiber-Seq and HiFi sequencing, advancing single-molecule epigenomics with new chromatin mapping tools.
MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain?
Myriad Genetics' GeneSight test outperforms treatment-as-usual in major depression, raising hopes for broader adoption and renewed stock momentum.
Here's Why You Should Hold Cencora Stock in Your Portfolio Now
COR gains from strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose risks.
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
ECL's strong Q2 results, innovation pipeline, and high-tech growth drivers support its long-term expansion despite macro headwinds.
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Accenture ( NYSE:ACN ) , Academy Sports ( NASDAQ:ASO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B of A Securities analyst Alec Stranahan downgraded Erasca, Inc.
HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y
HQY's Q2 results reflect EPS growth of 25.6% year over year, revenue growth of 8.6% and a 12% increase in HSA. The company also updates its fiscal 2026 guidance.
STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep
Stereotaxis debuts MAGiC Sweep, the first U.S. robotic HD mapping catheter, marking a breakthrough in cardiac arrhythmia diagnosis and treatment.
IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection
iRhythm's AMALFI trial shows its Zio monitoring service boosts AF detection and speeds diagnosis, strengthening its edge in cardiac care.
GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System
GE HealthCare's Vivid Pioneer, cleared by CE Mark and FDA, brings AI-powered speed, precision and efficiency to cardiac imaging.
ABT Stock Gains From Navitor's Expanded Indication Approval in Europe
Abbott wins CE Mark in Europe for expanded Navitor use, boosting its Structural Heart business and lifting ABT stock.
FDA Identifies ICU Medical's Plum Duo Recall as Serious Type
ICUI faces an FDA recall of its Plum Duo Infusion System over software flaws, though devices remain in use, pending fixes.
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
